SYDNEY-In an attempt to cure diabetes, an Australian researcher has developed a drug that may fight fat.
Frank NG of Melbourne's Monash University reports the drug has completed two human trials and is fairing well. No serious side effects have been reported. The drug, called Advanced Obesity Drug 9604, is created from an aspect of human growth hormones that research showed reduces body fat.
Created with help from Melbourne-based Metabolic Pharmaceuticals Ltd., officials reported 22 trial participants received the drug intravenously and found it to be safe. They lost an average of 1.1 pounds during the 4-week trial.
The research in body-weight reducing drugs is increasing after officials from the World Health Organization (WHO) reported 300 million people are estimated to have diabetes by 2025. Non-communicable diseases, such as diabetes Type 2, are set to become a pandemic within this century.
Information from www.reuters.com
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.